Potent and orally efficacious PROTAC degraders of estrogen receptor α (ER α )

被引：0
|
作者：
Rej, Rohan K.
Chen, Zhixiang
Acharyya, Ranjan K.
Wu, Dimin
Hu, Biao
Xu, Guozhang
Nagilla, Rakesh
Metwally, Hoda
Wang, Yu
Wen, Bo
Sun, Duxin
Bai, Longchuan
Wang, Shaomeng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4510
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)
    Rej, Rohan Kalyan
    Hu, Biao
    Chen, Zhixiang
    Acharyya, Ranjan Kumar
    Wu, Dimin
    Metwally, Hoda
    Mceachern, Donna
    Wang, Yu
    Jiang, Wei
    Bai, Longchuan
    Nishimura, Leticia S.
    Gersch, Christina L.
    Wang, Meilin
    Wen, Bo
    Sun, Duxin
    Carlson, Kathryn
    Katzenellenbogen, John A.
    Xu, Guozhang
    Zhang, Weihong
    Wu, Wenxue
    Priestley, E. Scott
    Sui, Zhihua
    Rae, James M.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 20933 - 20965
  • [2] Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER plus Human Breast Cancer
    Acharyya, Ranjan Kumar
    Rej, Rohan Kalyan
    Hu, Biao
    Chen, Zhixiang
    Wu, Dimin
    Lu, Jianfeng
    Metwally, Hoda
    Mceachern, Donna
    Wang, Yu
    Jiang, Wei
    Bai, Longchuan
    Tosovic, Jelena
    Gersch, Christina L.
    Xu, Guozhang
    Zhang, Weihong
    Wu, Wenxue
    Priestley, E. Scott
    Sui, Zhihua
    Sarkari, Farzad
    Wen, Bo
    Sun, Duxin
    Rae, James M.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (21) : 19010 - 19037
  • [3] Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity
    Chen, Zhixiang
    Hu, Biao
    Rej, Rohan Kalyan
    Wu, Dimin
    Acharyya, Ranjan Kumar
    Wang, Mingliang
    Xu, Tianfeng
    Lu, Jianfeng
    Metwally, Hoda
    Wang, Yu
    Mceachern, Donna
    Bai, Longchuan
    Gersch, Christina L.
    Wang, Meilin
    Zhang, Wenjing
    Li, Qiuxia
    Wen, Bo
    Sun, Duxin
    Rae, James M.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (17) : 12559 - 12585
  • [4] Discovery of potent, highly selective and orally efficacious SMARCA2 degraders
    Leng, Lingying
    Yang, Lin
    Tu, Wenbin
    Rej, Rohan
    Allu, Srinivasa Rao
    Huang, Liyue
    Jiang, Wei
    Wang, Yu
    Stuckey, Jeanne
    Sarkari, Farzad R.
    Wang, Meilin
    Wang, Lu
    Wen, Bo
    Sun, Duxin
    Wang, Shaomeng
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Discovery of Exceptionally Potent, Selective, and Efficacious PROTAC Degraders of CBP and p300 Proteins
    Thomas, Junius Eugene
    Wang, Mi
    Jiang, Wei
    Wang, Meilin
    Wang, Lu
    Wen, Bo
    Sun, Duxin
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 8178 - 8199
  • [6] Identification and development of oral estrogen receptor PROTAC degraders for breast cancer
    Flanagan, John J.
    Qian, Yimin
    Gough, Sheryl M.
    Andreoli, Monica
    Bookbinder, Mark
    Bradley, John
    Rousseau, Emma
    Willard, Ryan
    Crews, Craig M.
    Crew, Andrew P.
    Taylor, Ian
    Houston, John
    CANCER RESEARCH, 2018, 78 (04)
  • [7] The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs)
    Wang, Lucia
    Sharma, Abhishek
    CHEMMEDCHEM, 2020, 15 (22) : 2072 - 2097
  • [8] Dynamics-Based Discovery of Novel, Potent Benzoic Acid Derivatives as Orally Bioavailable Selective Estrogen Receptor Degraders for ERα plus Breast Cancer
    Zhang, Xiaomeng
    Wang, Yazhou
    Li, Xue
    Wu, Jie
    Zhao, Liwen
    Li, Wei
    Liu, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (11) : 7575 - 7595
  • [9] New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons
    Wang, Lucia
    Guillen, Valeria S.
    Sharma, Naina
    Flessa, Kevin
    Min, Jian
    Carlson, Kathryn E.
    Toy, Weiyi
    Braqi, Sara
    Katzenellenbogen, Benita S.
    Katzenellenbogen, John A.
    Chandarlapaty, Sarat
    Sharma, Abhishek
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (08): : 803 - 808
  • [10] Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
    Hu, Jiantao
    Hu, Biao
    Wang, Mingliang
    Xu, Fuming
    Miao, Bukeyan
    Yang, Chao-Yie
    Wang, Mi
    Liu, Zhaomin
    Hayes, Daniel F.
    Chinnaswamy, Krishnapriya
    Delproposto, James
    Stuckey, Jeanne
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1420 - 1442
12345